Surnrnary A genotypic method for predicting rifampicin resistance in My cobacter iurn leprae has been developed and rigorously tested on mouse footpad-derived and clinical specimens. A series of immobilized oligonucleotide capture probes can discriminate between wild type and mutant rpoB alleles, and positive controls are available for the most frequent mutation affecting Ser425. Two different non radioactive detection formats have been tested with comparable success in both an industrialized and a developing country. The standardized procedure could now be used in a prospective study of potential rifampicin resistance among multibacillary patients.
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Rifampicin is the backbone of the multidrug therapy currently used to treat leprosy l . 2 and it, or a related rifamycin, will almost certainly be inc1uded in any new regimens that may be developed ? Fortunately, resistance to rifampicin is rare and has only been documented in a limited number of lepromatous patients, mostly receiving monotherapy or other inadequate treatment. 4 On characterization, all rifampicin resistant isolates of My cobacterium leprae were found to harbour mis-sense mutations in a short segment of the rpoB gene, encoding the {j-subunit of DNA-dependent RNA polymerase. 5 -8 The sarne region, termed RIF-RDR has been shown to be associated with rifampicin resistance in almost all resistant isolates, of My cobacterium tuberculosis, 7 . 9 -1 2 and in a range of other bacteria. 13 • 14 Testing M. leprae isolates for rifampicin susceptibility is generally performed after inoculation of mice 15 but this is expensive and requires specialized resources that are gradually disappearing from leprosy control programmes. Radio-respirometry is a useful, more rapid altemative 1 6 but this also needs a sophisticated laboratory infrastructure and relatively large numbers of metabolically active organisms that can only be obtained by passage and growth in experimental animaIs. ln recent years, severa! groups have estab lished predictive molecular methods for detecting rifampicin resistance that are based on the rp oB genotype. The first such approach involved single strand conformation polymorph ism (SSCP)-PCR, 6 yielding excellent results within 48 h and giving perfect agreement with those obtained from the mouse. Similar results were subsequently obtained using PCR facilitated heteroduplex analysis (RDA) of rp oB 7 and this method has also been applied to detecting dapsone resistance. l 7 Rowever, both PCR-SSCP and PCR-RDA require gel electrophoresis and sophisticated laboratory equipment and may not be suitable for resource poor settings. Rere we describe the development of a simpler method for predicting rifampicin resistance, involving solid-phase hybridization to oligonuc1eotide capture probes, and its application in the field.
Materiais and methods

MEMBRANE PREPARATION
Oligonuc1eotides corresponding to both strands of the RIF-RDR region were designed ( Figure 1 , Table 1 ) then tested empirically for use as capture probes. The best results were obtained with probes corresponding to the complementary strand so these were then used exc1usively. Capture probes were synthesized with a 5 ' -amino group to facilitate covalent linkage to Biodyne C membranes and diluted to the optimized concentrations in 350 1L1 of 500 mM NaRC0 3 , pR 8.4. Membranes (9·5 x 7 cm) were activated by incubation in 20 ml freshly prepared 16% (w/v) l-ethyl-3-(3-dimethylaminopropyl) carbodiimide (EDAC), with shaking at room temperature for 10 min, rinsed with water and placed in a c1ean miniblotter system. Diluted oligonuc1eotides solutions (350 1L1) were added to the slots and left for 5 min before removal. The membrane was removed from the miniblotter, inactivated in 100 mM NaOR for 10 min, then washed in 2 x SSPE/O·l % SDS for 5 min at 60°C. After washing in 20 mM EDTA pR 8, for 15 min, membranes were stored at 4°C in Saranwrap, then cut into appropriate strips before use. Table I . 
PREPARATION OF BIOTINYLATEO PROBES ANO ONA SEQUENCING
PCR was performed using the primers B-rp022 and rp032 (Table 1) , where B-rp022 is biotinylated, with samples of M. lepra e DNA prepared by the freeze-boiling method, 1 8 as described previously. 5 For control purposes, plasmids carrying c10ned RIF-RDR from wild type and three rifampicin resistant isolates of M. leprae were used in PCR reactions. ln some experiments, DNA sequencing was performed to confirm the presence of mutations predicted by the kit. Primers B-rp022 and rp032 were used to generate a PCR fragment spanning the RIF-RDR, which was then sequenced using primer rpoB46 (Table 1 ) and fluorescent big dye terminators. Sequences were obtained using an ABI373 automated sequencer.
HY B RIDIZATION ANO OETECTION
This requires the following prewarmed buffers (20°C, unless specified otherwise): denatura tion buffer (DB) 2 M NaOH/2 mM EDTA; hybridization buffer (HB) 6 x SSPE/O·l % SDS, 50°C ; washing buffer (WB 1) 4 x SSPE/O·l % SDS, 55°C,and 42°C; washing buffer (WB2) 2 x SSPE/O·l % SDS; washing buffer (WB3) 2 x SSPE; staining buffer (SB) 0·1 M Tris-buffer pR 9·5/0·05 M MgCI 2 , 0·1 M NaCl. PCR fragments were denatured in an equal volume of DB for 5 min then added to prewarmed RB (1 mI, 55°C), and incubated with the strips, in a shaking water-bath at 50°C, for 30-60 min. After discarding the hybridization solution and washing the strips with 2 mI of prewarmed WB 1 for 15 min, the appropriate streptavidin-conjugate in WB 1 (2 mI, 42°C) was added and incubated for 30-60 mino Streptavidin-peroxidase conjugate was diluted 1/4000 for chemiluminescent detection and streptavidin-alkaline phosphatase conjugate was diluted 1/1000 for colorimetric detection. After discarding the conjugate solution, strips were washed with 2 mI of WB2 for 10 min before adding 2 mI of WB3 and washing for 10 mino For chemiluminescent detection, strips were incubated for 2 min in 2 mI ECL detection liquid (Amersham), washed, then covered with Saran-wrap and exposes to X-ray film for 1 mino For colorimetric detection, 2 mI of diluted NBT/BCIP stock solution in SB (200 1-'1/10 mI), was added and the strips incubated for 15-60 mino
Results
STANDARDIZING THE METHOD
The aim of this work was to construct and standardize a kit that allows mutations to be detected in the rpoB gene of M. leprae, and hence to predict whether the corresponding isolates would be sensitive or resistant to rifampicin. The approach involved the synthesis of a series of oligonuc1eotide capture probes spanning the lower strand of the RIF-RDR, their immobilization on a nylon membrane and use in reverse hybridization experiments. Many oligonuc1eotide probes of different lengths spanning RIF-RDR were synthesized, bound to the membrane then tested with biotinylated probes prepared from wild type and mutant rp oB alleles by PCR. The optimal combination of oligonuc1eotides, their sequence and location is shown in Figure 1 . We found that the best results were obtained by combining four 23-mer probes with six (or seven) 17-mer probes for the bottom strand. Hybridization results were uneven in initial experiments with the shorter probes, probably due to steric hindrance from the membrane resulting in less of the capture probe being available to forrn hybrids. Consequently, these probes were resynthesized with three additional deoxyadenosine residues at the 5 ' -end thereby allowing better access of the biotinylated PCR fragment to the 17-mer capture sequence.
To date, only a limited number of mutations responsible for rifampicin resistance have been reported in M. leprae. 5 , 7 The amino acid substitutions involved are His420Asp (position 525 in Escherichia coZi), Ser425Leu, Ser425Met and Ser425Phe. For control purposes, 17-mer capture probes (with 5 ' -adenosine) corresponding to mutant rpoB alleles of Ser425 were also synthesized and inc1uded on the membranes. This proved particularly useful as the DNA sequence encompassing Ser425 is very GC-rich and readily adopts stable secondary structures that often prec1ude hybridization.
Typical results obtained with this method are shown in Figure 2 . Hybridization to capture probes 1-4 is seen in alI cases except when a mutation affecting the codon for His420 is present as probe 4 then displayed no signal (column 5). Mutations affecting this codon can also be detected with probe A35. Probe 4 also covers part of the mutational hot-spot corresponding to codon 425 but does not detect mutations affecting this position probably because the site is too c10se to the 5 ' -end of the capture probe for heteroduplex formation to be sufficiently destabilized. However, the shorter probe A27, in combination with the mutant probes A30Rl, A32R3 and A33R9, allows alI known mutations affecting codon 425 to be detected efficiently ( Figure 2, columns 2, 3 and 4) . The mutant probes displayed excellent specificity as no signals due to crosshybridization with the wild type rpoB gene were obtained. Probes A34 and A37 sometimes displayed weaker signals than the others but the corresponding region are well covered by probes A27 and 4, or 2 and 3, respectively (Figure 1 ). Mutations were correctly revealed under standard laboratory conditions using either colorimetric or chemilurninescent detection methods. Figure 2 . Detection of rifampicin resistance by reverse hybridization. The results were obtained using the protocol described in Materiais and methods with biotinylated probes generated by peR using M. leprae DNA from the following sources: column 1, wild type M. leprae; column 2, positive control rp oBSer425Leu; column 3, positive control rp oBSer425Met; column 4, positive control rp oBSer425Phe; column 5, strain 9204 1 with rp oBHis420Asp mutation. The capture probes are indicated on the right, for further details see Table 1 or Figure 1 .
BLlND TESTING
Having established that the method reproducibly detected the common rp oB mutations at our disposal, it was then evaluated blindly on a set of six uncharacterized M. Zeprae isolates. Five of these proved to be wild type for rpoB (represented in column 2, Figure 3 ), but one of them appeared to harbour an rp oB mutation as no signal was obtained with capture probes 3 and A36 (column 1, Figure 3) . These results were confirmed by DNA sequencing of PCR fragments spanning the RIF-RDR as the missense mutation Ser4 16Cys (TCG->TGT) was uncovered. Mutation of this residue to Leu and Ser has been reported in rifampicin resistant isolates of M. tubercuZosis and E. coZi, respectively. 9 . 1 1 , 13
FIELD TESTING
Kits for detecting rifampicin resistance were established in Paris then tested in Kathmandu at the Anandaban Leprosy Hospital. The results obtained there were of comparable quality to those generated in France as were those obtained with membranes produced locally. A potential case of rifampicin resistance was successfully detected in a mouse footpad-derived specimen. The corresponding strain was predicted to harbour a Ser425Phe mutation by solid phase hybridization and this was confirmed by DNA sequencing. An M. Zeprae isolate harboring the corresponding allele has previously been shown to be drug resistant in the mouse mode1. 4 , 5 Having validated the system, attempts were then made to apply it to clinical specimens obtained from leprosy patients. Skin biopsies were collected from -60 lepromatous leprosy patients in Nepal and India, stored in 70% ethanol, then transported to the Anandaban Leprosy Hospital for further analysis. Most of these patients had either relapsed or not responded to treatment. After rehydration and rnincing, the biopsies were prepared for PCR analysis by freeze-boiling. Qnly tive samples reproducibly yielded PCR fragments and these were used successfully with the cherniluminescent detection system. Two samples from patients who had not res ponded to treatment were found to be resistant by both methods and harboured the Ser425Phe mutation. The remaining three samples were found to be wild type, or rifampicin-susceptible, by both methods.
This study has convincingly demonstrated that detection of rifampicin resistance by mole cular methods is a feasible and practical altemative to the mouse footpad assay. Equivalent results were obtained using two different non-radioactive detection systems in laboratories : in France and Nepal. There is thus no technical reason why a kit such as that described here should not find more extensive application in developing countries. A similar method has been deve10ped for detecting rifampicin resistant M. tuberculosis and is now commercially available. 1 9 It has yielded satisfactory results in several settings. 1O The availability of the M. leprae genome sequence also provides us with means to develop genotypic methods for detecting resistance to other drugs. This could now be done for dapsone and ftuoroquino lones and, in the near future for other therapeutic agents as information about the molecular basis of resistance becomes available. We believe that the time is now right to extend the study and to learn from the present work as this approach has much to offer leprosy control programmes. ln the next phase, a much larger number of specimens should be tested. Although every available mutation has been detected by the reverse hybridization system, the number of sites within rpoB that can be monitored by positive controls is limited by the restricted set of base changes described. 5 -7 As a result, the faint possibility that new mutations might be missed by the system cannot yet be excluded and more extensive evaluation is required.
This could be done in the framework of a prospective study of rifampicin resistance in which skin biopsies are examined from ex-multibacillary leprosy patients who have not responded properly to the treatment of MDT. Combined with PCR-based, DNA sequence analysis of the rpoB gene from M. leprae extracted from the biopsies rigorous appraisal of the reverse hybridization kit would be obtained and valuable information about the leveI of rifampicin resistance generated. Such a study would also enable us to evaluate, in a systematic manner, the long-term efficacy of multidrug therapy for multibacillary leprosy.
